In July 2020, the FDA Cardiovascular and Renal Drugs Advisory Committee narrowly voted 8 to 7 in favor of the approval of terlipressin for HRS-1.
In patients with acidemia, hypobicarbonatemia conferred a considerable risk of kidney failure requiring renal replacement therapy after adjusting for potential confounders.
The newest KDOQI guideline for renal nutrition, which took 5 years to develop, expands recommendations to include patients with all stages of chronic kidney disease.
Those with higher-risk episodes for ESRD as young adults had poorer cognitive performance at midlife.
A simplified creatinine index reflects the creatinine generation rate of individual patients on hemodialysis.
Dapagliflozin appears to preserve kidney function and improve survival in patients with chronic kidney disease whether or not they have type 2 diabetes.
Each level of worsening hyponatremia among patients hospitalized with COVID-19 was significantly associated with 43% increased odds of dying in the hospital, a study found.
65% of couples using IVF who selected testing had at least one live birth of an unaffected child.
In a trial, empagliflozin reduced the risks for heart failure hospitalization and renal outcomes in patients with heart failure with reduced ejection fraction.
Survey shows 23.2% of those who want CPR in the event of cardiac arrest value life prolongation.